[DPHARMA] YoY TTM Result on 30-Jun-2021 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
17-Aug-2021
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2021
Quarter
30-Jun-2021 [#2]
Profit Trend
QoQ- 1.05%
YoY- 14.75%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 748,028 697,025 684,965 589,751 582,654 537,324 484,882 7.48%
PBT 60,522 81,539 87,730 82,412 70,825 70,598 53,202 2.16%
Tax -11,084 -12,855 -18,449 -19,088 -15,643 -15,562 -9,321 2.92%
NP 49,438 68,684 69,281 63,324 55,182 55,036 43,881 2.00%
-
NP to SH 49,438 68,684 69,281 63,324 55,182 55,036 44,396 1.80%
-
Tax Rate 18.31% 15.77% 21.03% 23.16% 22.09% 22.04% 17.52% -
Total Cost 698,590 628,341 615,684 526,427 527,472 482,288 441,001 7.96%
-
Net Worth 692,598 670,448 634,375 614,350 581,725 503,029 209,983 21.98%
Dividend
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Div 26,934 21,929 21,685 45,892 37,536 33,094 20,937 4.28%
Div Payout % 54.48% 31.93% 31.30% 72.47% 68.02% 60.13% 47.16% -
Equity
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Net Worth 692,598 670,448 634,375 614,350 581,725 503,029 209,983 21.98%
NOSH 961,942 961,942 952,239 706,330 684,383 661,881 650,902 6.72%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin 6.61% 9.85% 10.11% 10.74% 9.47% 10.24% 9.05% -
ROE 7.14% 10.24% 10.92% 10.31% 9.49% 10.94% 21.14% -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
RPS 77.76 72.77 72.34 83.52 85.14 81.18 173.19 -12.48%
EPS 5.14 7.17 7.32 8.97 8.06 8.32 15.86 -17.10%
DPS 2.80 2.30 2.30 6.50 5.50 5.00 7.50 -15.13%
NAPS 0.72 0.70 0.67 0.87 0.85 0.76 0.75 -0.67%
Adjusted Per Share Value based on latest NOSH - 706,330
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
RPS 77.70 72.41 71.15 61.26 60.53 55.82 50.37 7.48%
EPS 5.14 7.13 7.20 6.58 5.73 5.72 4.61 1.82%
DPS 2.80 2.28 2.25 4.77 3.90 3.44 2.17 4.33%
NAPS 0.7195 0.6965 0.659 0.6382 0.6043 0.5225 0.2181 21.98%
Price Multiplier on Financial Quarter End Date
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Date 28/06/24 30/06/23 30/06/22 30/06/21 30/06/20 28/06/19 29/06/18 -
Price 1.26 1.30 1.20 3.03 1.62 1.37 1.30 -
P/RPS 1.62 1.79 1.66 3.63 1.90 1.69 0.75 13.68%
P/EPS 24.52 18.13 16.40 33.79 20.09 16.48 8.20 20.00%
EY 4.08 5.52 6.10 2.96 4.98 6.07 12.20 -16.67%
DY 2.22 1.77 1.92 2.15 3.40 3.65 5.77 -14.70%
P/NAPS 1.75 1.86 1.79 3.48 1.91 1.80 1.73 0.19%
Price Multiplier on Announcement Date
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Date 15/08/24 24/08/23 16/08/22 17/08/21 13/08/20 30/08/19 26/11/18 -
Price 1.17 1.19 1.34 2.49 3.15 1.41 1.08 -
P/RPS 1.50 1.64 1.85 2.98 3.70 1.74 0.62 15.84%
P/EPS 22.77 16.59 18.31 27.77 39.07 16.96 6.81 22.26%
EY 4.39 6.03 5.46 3.60 2.56 5.90 14.68 -18.20%
DY 2.39 1.93 1.72 2.61 1.75 3.55 6.94 -16.26%
P/NAPS 1.62 1.70 2.00 2.86 3.71 1.86 1.44 1.98%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment